New pill shows promise in early trial for Hard-to-Treat cancers
NCT ID NCT05142592
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 23 times
Summary
This early-phase study tests an experimental oral drug called IPG7236 in people with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 196 adults will take the drug twice daily in 28-day cycles.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NEXT Oncology
RECRUITINGAustin, Texas, 12221, United States
Contact
-
Providence Portland Medical Center
RECRUITINGPortland, Oregon, 97222, United States
Contact
-
Shandong Cancer Hospital
RECRUITINGJinan, Shangdong, China
Contact
-
Shanghai East Hospital
RECRUITINGShanghai, China
Contact
-
Shanghai General Hospital
ACTIVE_NOT_RECRUITINGShanghai, China
-
Shanghai GoBroad Cancer Hospital China Pharmaceutical University
RECRUITINGShanghai, China
Contact
-
The First Affiliated Hospital Nanchang Univeristy
RECRUITINGNanchang, Jiangxi, China
Contact
Conditions
Explore the condition pages connected to this study.